---
title: "The observation status for Diagonal Bio AB is removed"
date: "2025-02-11 20:38:56"
summary: "Nasdaq Stockholm ABFirst North Growth Market - EquitiesThe observation status for Diagonal Bio AB is removedOn November 11, 2024, Diagonal Bio AB (the “Company”) was given observationstatus with reference to material adverse uncertainty in respect of theCompany's financial position.On February 7, 2025, the Company disclosed a press release with information..."
categories:
  - "Reuters"
lang:
  - "en"
translations:
  - "en"
tags:
  - "Reuters"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Nasdaq Stockholm ABFirst North Growth Market - Equities

The observation status for Diagonal Bio AB is removed

On November 11, 2024, Diagonal Bio AB (the “Company”) was given observationstatus with reference to material adverse uncertainty in respect of theCompany's financial position.

On February 7, 2025, the Company disclosed a press release with information onthe outcome of a rights issue.

With reference to the above, Nasdaq Stockholm AB decides that the observationstatus for the shares (DIABIO, ISIN code SE0015961826, order book ID 227665)and paid subscription units (DIABIO BTU, ISIN code SE0023615984, order book ID381705) in Diagonal Bio AB shall be removed.

For further information about this exchange notice please contact Enforcement &Investigations, telephone +46 8 405 70 50.

Nasdaq Stockholm ABhttps://view.news.eu.nasdaq.com/view?id=b7339ae234765f100d9f3cc013522091a&lang=en&src=omxlink

[Reuters](https://www.tradingview.com/news/reuters.com,2025-02-11:newsml_SSNdS4l:0-the-observation-status-for-diagonal-bio-ab-is-removed/)
